- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退,要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23Q4 (20) | 57 | 0.0 | 1.79 | -0.63 | -8.62 | -270.59 | -0.44 | 18.52 | -214.29 | -1.82 | -52.94 | -49.18 | 0.76 | 33.33 | -29.63 | 20.53 | 70.37 | -21.85 | -0.31 | 18.42 | -244.44 | -0.36 | -9.09 | -260.0 | -54.90 | 22.64 | -439.29 | -47.27 | 18.23 | -421.17 | -6.19 | -147.65 | -48.74 |
23Q3 (19) | 57 | 0.0 | 0.0 | -0.58 | -286.67 | -544.44 | -0.54 | -116.0 | -350.0 | -1.19 | -95.08 | -13.33 | 0.57 | -45.71 | -49.11 | 12.05 | -60.62 | -39.11 | -0.38 | -153.33 | -442.86 | -0.33 | -266.67 | -560.0 | -70.97 | -641.59 | -1403.6 | -57.81 | -586.58 | -1193.29 | 22.60 | -109.64 | -36.41 |
23Q2 (18) | 57 | 0.0 | 0.0 | -0.15 | 67.39 | 65.91 | -0.25 | 43.18 | 45.65 | -0.61 | -32.61 | 37.11 | 1.05 | 90.91 | 69.35 | 30.60 | 43.93 | 73.86 | -0.15 | 50.0 | 54.55 | -0.09 | 65.38 | 64.0 | -9.57 | 83.02 | 81.49 | -8.42 | 82.23 | 79.42 | 20.92 | -51.60 | -85.55 |
23Q1 (17) | 57 | 1.79 | 5.56 | -0.46 | -170.59 | 13.21 | -0.44 | -214.29 | 21.43 | -0.46 | 62.3 | 13.21 | 0.55 | -49.07 | -8.33 | 21.26 | -19.07 | 76.14 | -0.3 | -233.33 | 23.08 | -0.26 | -160.0 | 10.34 | -56.36 | -453.63 | 6.38 | -47.39 | -422.49 | 8.67 | -26.32 | -129.74 | -115.48 |
22Q4 (16) | 56 | -1.75 | 9.8 | -0.17 | -88.89 | -183.33 | -0.14 | -16.67 | -800.0 | -1.22 | -16.19 | -339.22 | 1.08 | -3.57 | -28.48 | 26.27 | 32.74 | -6.94 | -0.09 | -28.57 | -212.5 | -0.1 | -100.0 | -233.33 | -10.18 | -115.68 | -515.51 | -9.07 | -102.91 | -868.64 | 38.54 | -4.67 | 28.62 |
22Q3 (15) | 57 | 0.0 | 11.76 | -0.09 | 79.55 | 35.71 | -0.12 | 73.91 | -71.43 | -1.05 | -8.25 | -284.21 | 1.12 | 80.65 | -13.18 | 19.79 | 12.44 | -22.73 | -0.07 | 78.79 | -333.33 | -0.05 | 80.0 | 28.57 | -4.72 | 90.87 | -728.07 | -4.47 | 89.07 | -179.37 | 41.99 | 48.27 | 45.88 |
22Q2 (14) | 57 | 5.56 | 11.76 | -0.44 | 16.98 | -158.67 | -0.46 | 17.86 | 0.0 | -0.97 | -83.02 | -236.62 | 0.62 | 3.33 | 100.0 | 17.60 | 45.82 | -61.83 | -0.33 | 15.38 | -450.0 | -0.25 | 13.79 | -165.79 | -51.69 | 14.14 | -127.01 | -40.91 | 21.16 | -132.53 | -28.46 | -383.18 | -1441.07 |
22Q1 (13) | 54 | 5.88 | 8.0 | -0.53 | -783.33 | -960.0 | -0.56 | -2900.0 | -166.67 | -0.53 | -203.92 | -960.0 | 0.6 | -60.26 | 172.73 | 12.07 | -57.24 | 129.47 | -0.39 | -587.5 | -200.0 | -0.29 | -866.67 | -1350.0 | -60.20 | -2557.14 | -501.4 | -51.89 | -4497.46 | -405.26 | -21.60 | -363.10 | -1385.71 |
21Q4 (12) | 51 | 0.0 | 10.87 | -0.06 | 57.14 | 0.0 | 0.02 | 128.57 | 109.52 | 0.51 | -10.53 | 136.96 | 1.51 | 17.05 | 277.5 | 28.23 | 10.23 | 185.44 | 0.08 | 166.67 | 180.0 | -0.03 | 57.14 | 0.0 | 2.45 | 529.82 | 170.0 | 1.18 | 173.75 | 118.27 | 166.59 | -30.77 | 106.67 |
21Q3 (11) | 51 | 0.0 | 13.33 | -0.14 | -118.67 | 78.46 | -0.07 | 84.78 | 82.5 | 0.57 | -19.72 | 143.18 | 1.29 | 316.13 | 248.65 | 25.61 | -44.46 | 257.02 | 0.03 | 150.0 | 112.5 | -0.07 | -118.42 | 75.86 | -0.57 | -100.3 | 99.29 | -1.60 | -101.27 | 98.01 | 178.52 | 740.66 | -17.13 |
21Q2 (10) | 51 | 2.0 | 10.87 | 0.75 | 1600.0 | 270.45 | -0.46 | -119.05 | -43.75 | 0.71 | 1520.0 | 204.41 | 0.31 | 40.91 | -22.5 | 46.11 | 776.62 | 732.31 | -0.06 | 53.85 | 68.42 | 0.38 | 2000.0 | 290.0 | 191.36 | 2011.69 | 483.33 | 125.78 | 1324.73 | 350.46 | -2.05 | 808.34 | -59.52 |
21Q1 (9) | 50 | 8.7 | 8.7 | -0.05 | 16.67 | 78.26 | -0.21 | 0.0 | 19.23 | -0.05 | 96.38 | 78.26 | 0.22 | -45.0 | -38.89 | 5.26 | -46.81 | 636.73 | -0.13 | -30.0 | -8.33 | -0.02 | 33.33 | 81.82 | -10.01 | -186.0 | 58.33 | -10.27 | -58.98 | 64.97 | -18.45 | 53.72 | 23.75 |
20Q4 (8) | 46 | 2.22 | 0.0 | -0.06 | 90.77 | 85.37 | -0.21 | 47.5 | 25.0 | -1.38 | -4.55 | -130.0 | 0.4 | 8.11 | -81.82 | 9.89 | 160.64 | 1766.04 | -0.1 | 58.33 | 37.5 | -0.03 | 89.66 | 84.21 | -3.50 | 95.63 | 59.3 | -6.46 | 91.98 | 24.8 | 0.30 | 21.52 | 11.25 |
20Q3 (7) | 45 | -2.17 | -2.17 | -0.65 | -47.73 | -285.71 | -0.40 | -25.0 | -471.43 | -1.32 | -94.12 | -594.74 | 0.37 | -7.5 | -68.38 | -16.31 | -394.4 | -258.35 | -0.24 | -26.32 | -1100.0 | -0.29 | -45.0 | -281.25 | -80.12 | -60.5 | -625.38 | -80.54 | -60.37 | -690.47 | 1.80 | -69.52 | -24.04 |
20Q2 (6) | 46 | 0.0 | 0.0 | -0.44 | -91.3 | -62.96 | -0.32 | -23.08 | 3.03 | -0.68 | -195.65 | -25.93 | 0.4 | 11.11 | -31.03 | 5.54 | 665.31 | 174.56 | -0.19 | -58.33 | 5.0 | -0.2 | -81.82 | -66.67 | -49.92 | -107.83 | -126.19 | -50.22 | -71.28 | -138.35 | -36.27 | -23.70 | -7.97 |
20Q1 (5) | 46 | 0.0 | 0.0 | -0.23 | 43.9 | 17.86 | -0.26 | 7.14 | -85.71 | -0.23 | 61.67 | 17.86 | 0.36 | -83.64 | 16.13 | -0.98 | -284.91 | -110.12 | -0.12 | 25.0 | -100.0 | -0.11 | 42.11 | 15.38 | -24.02 | -179.3 | 32.32 | -29.32 | -241.33 | 28.49 | - | - | 0.00 |
19Q4 (4) | 46 | 0.0 | 0.0 | -0.41 | -217.14 | 0.0 | -0.28 | -300.0 | 0.0 | -0.60 | -215.79 | 0.0 | 2.2 | 88.03 | 0.0 | 0.53 | -94.85 | 0.0 | -0.16 | -700.0 | 0.0 | -0.19 | -218.75 | 0.0 | -8.60 | -156.39 | 0.0 | -8.59 | -162.98 | 0.0 | - | - | 0.00 |
19Q3 (3) | 46 | 0.0 | 0.0 | 0.35 | 229.63 | 0.0 | -0.07 | 78.79 | 0.0 | -0.19 | 64.81 | 0.0 | 1.17 | 101.72 | 0.0 | 10.30 | 238.63 | 0.0 | -0.02 | 90.0 | 0.0 | 0.16 | 233.33 | 0.0 | 15.25 | 169.1 | 0.0 | 13.64 | 164.74 | 0.0 | - | - | 0.00 |
19Q2 (2) | 46 | 0.0 | 0.0 | -0.27 | 3.57 | 0.0 | -0.33 | -135.71 | 0.0 | -0.54 | -92.86 | 0.0 | 0.58 | 87.1 | 0.0 | -7.43 | -176.76 | 0.0 | -0.2 | -233.33 | 0.0 | -0.12 | 7.69 | 0.0 | -22.07 | 37.81 | 0.0 | -21.07 | 48.61 | 0.0 | - | - | 0.00 |
19Q1 (1) | 46 | 0.0 | 0.0 | -0.28 | 0.0 | 0.0 | -0.14 | 0.0 | 0.0 | -0.28 | 0.0 | 0.0 | 0.31 | 0.0 | 0.0 | 9.68 | 0.0 | 0.0 | -0.06 | 0.0 | 0.0 | -0.13 | 0.0 | 0.0 | -35.49 | 0.0 | 0.0 | -41.00 | 0.0 | 0.0 | - | - | 0.00 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/3 | 0.29 | 201.19 | 46.18 | 0.62 | 12.81 | 0.62 | N/A | - | ||
2024/2 | 0.1 | -58.1 | -52.95 | 0.33 | -6.22 | 0.49 | N/A | 本月營收,因中國疫情後整體消費力道減弱影響,故營業收入較去年同期大幅減少 | ||
2024/1 | 0.23 | 42.33 | 60.59 | 0.23 | 60.59 | 0.66 | N/A | 本月營收,因中國疫情後整體消費力道減弱影響,故營業收入較去年同期大幅減少 | ||
2023/12 | 0.16 | -38.72 | 19.36 | 2.93 | -16.35 | 0.76 | 0.59 | - | ||
2023/11 | 0.27 | -20.3 | -42.52 | 2.76 | -17.8 | 0.94 | 0.48 | - | ||
2023/10 | 0.33 | -0.19 | -29.29 | 2.5 | -13.85 | 0.77 | 0.58 | - | ||
2023/9 | 0.33 | 218.45 | -14.05 | 2.16 | -10.84 | 0.58 | 0.99 | - | ||
2023/8 | 0.11 | -22.1 | -70.47 | 1.83 | -10.22 | 0.54 | 1.06 | 本月營收主要因中國市場消費力下降,故營業收入較去年同期減少 | ||
2023/7 | 0.14 | -54.55 | -64.49 | 1.72 | 2.54 | 0.9 | 0.64 | 本月營收,因中國市場主要消費力下降,故營業收入較去年同期減少 | ||
2023/6 | 0.3 | -36.17 | -16.34 | 1.59 | 22.15 | 1.04 | 0.42 | - | ||
2023/5 | 0.47 | 70.34 | 80.58 | 1.29 | 36.62 | 0.94 | 0.46 | 本月營收,因中國疫情解封影響,故營業收入較去年同期大幅增加 | ||
2023/4 | 0.27 | 36.25 | 629.58 | 0.83 | 20.13 | 0.68 | 0.63 | 本月營收,因中國疫情解封影響,故營業收入較去年同期大幅增加 | ||
2023/3 | 0.2 | -3.06 | -4.26 | 0.55 | -15.0 | 0.55 | 1.07 | - | ||
2023/2 | 0.21 | 42.99 | 38.26 | 0.35 | -20.11 | 0.49 | 1.21 | - | ||
2023/1 | 0.14 | 5.79 | -50.18 | 0.14 | -50.18 | 0.74 | 0.79 | 本月營收,因中國疫情解封影響,故營業收入較去年同期大幅減少 | ||
2022/12 | 0.14 | -70.49 | -58.43 | 3.5 | -12.4 | 1.07 | 0.59 | 本月營收,因中國疫情解封影響,故營業收入較去年同期大幅減少 | ||
2022/11 | 0.46 | -1.95 | -14.71 | 3.36 | -8.27 | 1.33 | 0.48 | - | ||
2022/10 | 0.47 | 21.32 | -34.98 | 2.9 | -7.15 | 1.22 | 0.52 | - | ||
2022/9 | 0.39 | 9.4 | -38.33 | 2.43 | 1.29 | 1.13 | 0.66 | - | ||
2022/8 | 0.36 | -6.33 | -27.7 | 2.04 | 15.49 | 1.09 | 0.68 | - | ||
2022/7 | 0.38 | 7.07 | 5.7 | 1.68 | 32.24 | 0.99 | 0.75 | - | ||
2022/6 | 0.36 | 37.79 | -40.32 | 1.3 | 42.72 | 0.65 | 1.48 | - | ||
2022/5 | 0.26 | 588.22 | 537.65 | 0.94 | 199.31 | 0.5 | 1.9 | 本月營收,因對轉投資ACIM持有股權達100%,故將ACIM之5月營收合併納入,故造成整體營收大幅上升 | ||
2022/4 | 0.04 | -82.12 | -31.03 | 0.69 | 149.62 | 0.4 | 2.42 | 本月營收,因受中國疫情封城影響,故營業收入較去年同期大幅減少 | ||
2022/3 | 0.21 | 39.99 | 228.2 | 0.65 | 194.02 | 0.65 | 1.45 | 本月營收,因對轉投資ACIM持有股權達100%,故將ACIM之3月營收合併納入,故造成整體營收大幅上升 | ||
2022/2 | 0.15 | -48.48 | 345.82 | 0.44 | 180.14 | 0.77 | 1.22 | 本月營收,因對轉投資ACIM持有股權達100%,故將ACIM之2月營收合併納入,故造成整體營收大幅上升 | ||
2022/1 | 0.29 | -11.73 | 135.12 | 0.29 | 135.12 | 1.16 | 0.81 | 本月營收,因對轉投資ACIM持有股權達100%,故將ACIM之1月營收合併納入,故造成整體營收大幅上升 | ||
2021/12 | 0.33 | -39.45 | 87.92 | 3.99 | 165.11 | 1.6 | 0.61 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之12月營收合併納入,故造成整體營收大幅上升 | ||
2021/11 | 0.54 | -25.26 | 299.93 | 3.67 | 175.26 | 1.9 | 0.51 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之11月營收合併納入,故造成整體營收大幅上升 | ||
2021/10 | 0.73 | 15.07 | 995.61 | 3.12 | 161.09 | 1.85 | 0.52 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之9月營收合併納入,故造成整體營收大幅上升 | ||
2021/9 | 0.63 | 28.25 | 429.93 | 2.4 | 112.05 | 1.48 | 0.59 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之9月營收合併納入,故造成整體營收大幅上升 | ||
2021/8 | 0.49 | 36.95 | 304.72 | 1.76 | 74.53 | 1.45 | 0.6 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之8月營收合併納入,故造成整體營收大幅上升 | ||
2021/7 | 0.36 | -39.55 | 211.69 | 1.27 | 42.99 | 1.0 | 0.87 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之7月營收合併納入,故造成整體營收大幅上升 | ||
2021/6 | 0.6 | 1372.29 | 1775.51 | 0.91 | 17.81 | 0.69 | 1.26 | 本月營收,因對轉投資ACIM持有股權達51%,故將ACIM之6月營收合併納入,故造成整體營收大幅上升 | ||
2021/5 | 0.04 | -25.56 | -28.58 | 0.32 | -57.42 | 0.16 | 5.49 | 本月營收受中國肺炎疫情影響,市場消費力道衰退,故造成營收下滑 | ||
2021/4 | 0.05 | -14.91 | -83.12 | 0.28 | -59.8 | 0.15 | 5.74 | 因市場產能過剩,公司採取保守策略接單所致 | ||
2021/3 | 0.06 | 90.16 | -72.89 | 0.22 | -39.14 | 0.22 | 0.41 | 因市場產能過剩,公司採取保守策略接單所致 | ||
2021/2 | 0.03 | -72.83 | 18.71 | 0.16 | 23.17 | 0.33 | 0.27 | - | ||
2021/1 | 0.12 | -29.45 | 24.44 | 0.12 | 24.44 | 0.43 | 0.21 | - | ||
2020/12 | 0.18 | 28.84 | -56.28 | 1.51 | -62.76 | 0.38 | 0.27 | 因今年肺炎疫情影響接單狀況不佳,造成今年當月營收偏低 | ||
2020/11 | 0.14 | 104.74 | -88.07 | 1.33 | -63.47 | 0.32 | 0.31 | 因今年肺炎疫情影響接單狀況不佳,造成今年當月營收偏低 | ||
2020/10 | 0.07 | -44.33 | -86.53 | 1.2 | -52.28 | 0.31 | 0.33 | 因今年肺炎疫情影響接單狀況不佳,造成今年當月營收偏低 | ||
2020/9 | 0.12 | -2.04 | -71.6 | 1.13 | -43.9 | 0.36 | 0.25 | 因今年肺炎疫情影響接單狀況不佳,造成今年當月營收偏低 | ||
2020/8 | 0.12 | 5.47 | -75.95 | 1.01 | -36.6 | 0.27 | 0.33 | 因今年肺炎疫情影響接單狀況不佳,造成今年當月營收偏低 | ||
2020/7 | 0.12 | 263.72 | -46.72 | 0.89 | -18.26 | 0.2 | 0.44 | 本月營收受中國肺炎疫情影響,市場消費力道衰退,故造成營收下滑 | ||
2020/6 | 0.03 | -43.93 | -70.75 | 0.77 | -11.18 | 0.41 | 0.27 | 本月營收受中國肺炎疫情影響,市場消費力道衰退,故造成營收下滑 | ||
2020/5 | 0.06 | -82.4 | -64.97 | 0.74 | -2.7 | 0.61 | 0.18 | 本月營收受中國肺炎疫情影響,市場消費力道衰退,故造成營收下滑 | ||
2020/4 | 0.32 | 36.63 | 9.86 | 0.68 | 14.06 | 0.59 | 0.19 | - | ||
2020/3 | 0.24 | 732.89 | 12.55 | 0.36 | 18.06 | 0.36 | 0.3 | - | ||
2020/2 | 0.03 | -71.51 | 16.76 | 0.13 | 29.8 | 0.53 | 0.21 | - | ||
2020/1 | 0.1 | -75.21 | 34.06 | 0.1 | 34.06 | 1.64 | 0.07 | - | ||
2019/12 | 0.4 | -64.85 | 306.04 | 4.05 | 306.62 | 2.03 | 0.04 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/11 | 1.14 | 131.24 | 948.33 | 3.65 | 306.69 | 2.05 | 0.04 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/10 | 0.49 | 17.35 | 638.97 | 2.51 | 218.14 | 1.42 | 0.06 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/9 | 0.42 | -17.06 | 345.69 | 2.01 | 179.22 | 1.14 | 0.17 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/8 | 0.51 | 133.74 | 348.74 | 1.59 | 154.19 | 0.83 | 0.23 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/7 | 0.22 | 99.64 | 165.08 | 1.09 | 111.49 | 0.49 | 0.39 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/6 | 0.11 | -32.86 | 25.66 | 0.87 | 101.35 | 0.56 | 0.23 | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/5 | 0.16 | -44.8 | 100.32 | 0.76 | 120.25 | 0.0 | N/A | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 | ||
2019/4 | 0.29 | 39.97 | 315.59 | 0.6 | 126.31 | 0.0 | N/A | 因去年同月接單狀況不佳,基數較低,造成今年本月增加幅度偏高 |
加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 57 | 1.79 | -1.82 | 0 | -1.65 | 0 | 2.93 | -14.33 | 22.60 | 12.61 | -1.14 | 0 | -1.24 | 0 | -1.04 | 0 |
2022 (9) | 56 | 9.8 | -1.22 | 0 | -1.30 | 0 | 3.42 | 2.7 | 20.07 | -26.59 | -0.89 | 0 | -0.85 | 0 | -0.69 | 0 |
2021 (8) | 51 | 10.87 | 0.51 | 0 | -0.72 | 0 | 3.33 | 117.65 | 27.34 | 0 | -0.07 | 0 | 0.59 | 0 | 0.26 | 0 |
2020 (7) | 46 | 0.0 | -1.38 | 0 | -1.19 | 0 | 1.53 | -64.0 | -0.10 | 0 | -0.64 | 0 | -0.6 | 0 | -0.63 | 0 |
2019 (6) | 46 | 0.0 | -0.60 | 0 | -0.82 | 0 | 4.25 | 325.0 | 2.81 | 0 | -0.44 | 0 | -0.25 | 0 | -0.28 | 0 |
2018 (5) | 46 | 0.0 | -0.41 | 0 | -0.82 | 0 | 1.0 | -6.54 | -7.84 | 0 | -0.45 | 0 | -0.18 | 0 | -0.19 | 0 |
2017 (4) | 46 | 0.0 | -3.48 | 0 | -2.60 | 0 | 1.07 | -49.29 | -101.91 | 0 | -1.48 | 0 | -1.59 | 0 | -1.59 | 0 |
2016 (3) | 46 | 0.0 | -5.95 | 0 | -5.32 | 0 | 2.11 | -49.4 | -118.57 | 0 | -3.12 | 0 | -2.8 | 0 | -2.71 | 0 |
2015 (2) | 46 | 15.0 | -4.55 | 0 | -4.25 | 0 | 4.17 | -58.3 | -38.21 | 0 | -2.57 | 0 | -2.23 | 0 | -2.08 | 0 |
2014 (1) | 40 | 0.0 | 1.83 | -47.56 | 1.32 | -51.11 | 10.0 | -12.13 | 20.21 | 0 | 1.16 | -50.64 | 1.15 | -47.73 | 0.74 | -46.76 |